495 related articles for article (PubMed ID: 16546900)
1. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
[TBL] [Abstract][Full Text] [Related]
2. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
3. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
4. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
[TBL] [Abstract][Full Text] [Related]
5. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
6. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
7. Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells.
Kamida A; Fujita Y; Kato I; Iwai S; Ono K; Suzuki M; Sakurai Y; Yura Y
Int J Radiat Biol; 2008 Mar; 84(3):191-9. PubMed ID: 18300019
[TBL] [Abstract][Full Text] [Related]
8. Radiobiology of BNCT mediated by GB-10 and GB-10+BPA in experimental oral cancer.
Trivillin VA; Heber EM; Itoiz ME; Nigg D; Calzetta O; Blaumann H; Longhino J; Schwint AE
Appl Radiat Isot; 2004 Nov; 61(5):939-45. PubMed ID: 15308172
[TBL] [Abstract][Full Text] [Related]
9. Induction of multinucleation in oral squamous cell carcinoma tissue with mutated p53 surviving boron neutron capture therapy.
Fujita Y; Yamamoto N; Kato I; Iwai S; Ono K; Sakurai Y; Ohnishi K; Ohnishi T; Yura Y
Int J Radiat Biol; 2011 Mar; 87(3):293-301. PubMed ID: 21142704
[TBL] [Abstract][Full Text] [Related]
10. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
11. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; FarÃas S; Batistoni D; Schwint AE
Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
[TBL] [Abstract][Full Text] [Related]
12. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
Cardoso JE; Trivillin VA; Heber EM; Nigg DW; Calzetta O; Blaumann H; Longhino J; Itoiz ME; Bumaschny E; Pozzi E; Schwint AE
Int J Radiat Biol; 2007 Oct; 83(10):699-706. PubMed ID: 17729164
[TBL] [Abstract][Full Text] [Related]
13. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
14. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
Pisarev MA; Dagrosa MA; Thomasz L; Juvenal G
Medicina (B Aires); 2006; 66(6):569-73. PubMed ID: 17240633
[TBL] [Abstract][Full Text] [Related]
15. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP.
Viaggi M; Dagrosa MA; Longhino J; Blaumann H; Calzetta O; Kahl SB; Juvenal GJ; Pisarev MA
Appl Radiat Isot; 2004 Nov; 61(5):905-9. PubMed ID: 15308166
[TBL] [Abstract][Full Text] [Related]
16. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
19. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
Morris GM; Micca PL; Coderre JA
Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
[TBL] [Abstract][Full Text] [Related]
20. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME
Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
